4th Quarter - Report

COHERUS BIOSCIENCES for COHERUS BIOSCIENCES, INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$80,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report (this page) Oct 22, 2025 $80,000 Replaced
4th Quarter - Amendment Mar 9, 2026 $80,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to oncology, Medicare coverage, domestic production of essential drugs, supply chain security, PILLS Act, Biosecure Act, Loans and grants for biologic production

LobbyistCovered position, as disclosed
DAVID SANDERS Legislative Affairs, Dept of Commerce, US Patent and Trademark Office (2005-2007) Legislative Assistant, Representative Marsha Blackburn (2002-2004) Legislative and Press Intern, Senator Fred Thompson (2000)

Contacted: Executive Office of the President (EOP); White House Office; Office of Management & Budget (OMB); Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Defense, Dept of (DOD); SENATE; Centers For Medicare and Medicaid Services (CMS)

Government Issues GOV

Issues related to drug development, oncology, IRA implementation, supply chain security, BIOSECURE as a policy matter, PILLS Act, and domestic production of essential drugs. Strategic National Stockpile of acute radiation syndrome medical counter measures. Administration for Strategic Preparedness & Response.

LobbyistCovered position, as disclosed
DAVID SANDERS —

Contacted: Commerce, Dept of (DOC); Office of Management & Budget (OMB); White House Office; Centers For Medicare and Medicaid Services (CMS); President of the U.S.; Energy, Dept of; HOUSE OF REPRESENTATIVES; Defense Advanced Research Projects Agency (DARPA); SENATE; Defense Nuclear Facilities Safety Board; Vice President of the U.S.; Health & Human Services, Dept of (HHS); Federal Emergency Management Agency (FEMA); Food & Drug Administration (FDA); Natl Security Council (NSC); Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.